Search

Search Constraints

You searched for: Author/Creator Labonté, Anne

Search Results

1. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Issue 5 (29th September 2021)

3. CSF apolipoprotein B levels predict future visuospatial cognitive decline and synaptic pathology in cognitively unimpaired healthy elderly with a parental history of Alzheimer's disease. (31st December 2021)

4. F1‐03‐03: Mapping the progression of CSF and imaging biomarkers in "at‐risk" healthy subjects: The prevent‐ad program. (1st July 2015)

5. IC‐P‐154: Association between apolipoprotein a‐i levels and white matter hyperintensities depends on CSF tau levels in a high‐risk cohort of aging cognitively normal persons: The prevent‐alzheimer's disease study. (1st July 2015)

6. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults. (17th March 2020)

8. O5‐02‐06: The Association between white Matter Hyperintensities and Memory Impairment Depends on P‐TAU Levels in a High‐Risk Cohort of Aging Cognitively Normal Persons. (1st July 2016)